Authors: Gallwitz, B Ropeter, T Morys-Wortmann, C Mentlein, R Siegel, EG Schmidt, WE

Citation: B. Gallwitz et al., GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro, REGUL PEPT, 86(1-3), 2000, pp. 103-111

Authors: Siegel, EG Seidenstucker, A Gallwitz, B Schmitz, F Reinecke-Luthge, A Kloppel, G Folsch, UR Schmidt, WE

Citation: Eg. Siegel et al., Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1, J ENDOCR, 164(1), 2000, pp. 13-19

Authors: Siegel, EG Gallwitz, B Schmidt, WE Folsch, UR

Citation: Eg. Siegel et al., Hepatogenic diabetes - current concepts of its pathology and treatment, DEUT MED WO, 124(50), 1999, pp. 1530-1535

Authors: Siegel, EG Gallwitz, B Scharf, G Mentlein, R Morys-Wortmann, C Folsch, UR Schrezenmeir, J Drescher, K Schmidt, WE

Citation: Eg. Siegel et al., Biological activity of GLP-1-analogues with N-terminal modifications, REGUL PEPT, 79(2-3), 1999, pp. 93-102

Authors: Siegel, EG Scharf, G Gallwitz, B Mentlein, R Morys-Wortmann, C Folsch, UR Schmidt, WE

Citation: Eg. Siegel et al., Comparison of the effect of native glucagon-like peptide I and dipeptidyl peptidase IV-resistant analogues on insulin release from rat pancreatic islets, EUR J CL IN, 29(7), 1999, pp. 610-614